Davita Inc vs Super Micro Computer Inc — how do they compare? Davita Inc trades at $228.71 (market cap $14.92B), while Super Micro Computer Inc trades at $26.96 (market cap $17.89B). The key difference: Super Micro Computer Inc is the larger of the two by market cap, and Davita Inc is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals.
| DVA | SMCI | |
|---|---|---|
Market Cap | $14.92B | $17.89B |
Sector | Health | Technology |
52-Week High | $235.71 | $60.71 |
52-Week Low | $103.87 | $20.53 |
Enterprise Value | $27.47B | $25.40B |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $235.58, up 1.19% on the day, near its pivot point of $236. The stock shows a bullish technical trend with strong moving average signals, though RSI levels suggest potential overbought conditions. Fundamentally, revenue grew to $13.64B in 2025, but net income margin dipped to 5.65%. Recent earnings beat expectations in Q4 2025 and Q1 2026, while Q3 2025 missed. Analyst sentiment is mixed with a consensus price target of $231.80, slightly below the current price.
The outlook for DVA is cautiously optimistic, supported by steady revenue growth and expansion in kidney care services. Key risks include high debt levels, with debt-to-asset ratio rising to 65.55% in 2025, and margin pressure from rising costs. Investment opportunity lies in continued execution of value-based care programs and AI-driven efficiency gains, but investors should monitor debt management and regulatory changes in healthcare reimbursement.
Super Micro Computer (SMCI) trades at $27.66, down 2.3% for the day, reflecting recent bearish pressure amid a 56% decline from its 52-week high. The stock shows mixed technical signals with a bearish moving average trend but neutral oscillators. Fundamentally, the company reported strong revenue growth to $22.0B in 2025 and beat earnings expectations in recent quarters, though net margins compressed to 3.7% in 2026. Recent news highlights challenges including a Taiwan probe into AI server exports and cash flow strain from inventory buildup.
The outlook for SMCI is cautious near-term due to operational and regulatory headwinds, but long-term potential remains tied to AI infrastructure demand. Investment opportunity exists if the company can improve cash conversion and navigate competitive pressures, while risks include execution missteps and further margin erosion. Analyst consensus suggests upside to a $36.71 price target, but investor sentiment is tempered by recent volatility.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →